SCHEMBL22722751

SCHEMBL22722751

c1ccc(-c2nc(-c3ccc(-c4c(-c5ccccc5)c(-c5ccccc5)c(-c5ccccc5)c(-c5ccccc5)c4-c4ccccc4)cc3)nc(-c3cccc4ccccc34)n2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.54
ALDH1A1 P00352 6/20 0.54
HPGD P15428 6/20 0.54
SMN1; SMN2 Q16637 5/20 0.54
KDM4E B2RXH2 5/20 0.54
MAPK1 P28482 3/20 0.54
HSD17B10 Q99714 3/20 0.54
TSHR P16473 2/20 0.54
ATM Q13315 2/20 0.54
L3MBTL1 Q9Y468 2/20 0.54
TP53 P04637 2/20 0.54
NFKB1 P19838 1/20 0.54
NFKB2 Q00653 1/20 0.54
RELA Q04206 1/20 0.54
TDP1 Q9NUW8 1/20 0.54
ADORA3 P0DMS8 1/20 0.44
ALOX15 P16050 1/20 0.44
ADORA2A P29274 1/20 0.44
ADORA2B P29275 1/20 0.44
ADORA1 P30542 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22722781 0.93 MAPT (0.51) MAPTALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL15274131 0.93 MAPT (0.57) MAPTALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL15274132 0.93 MAPT (0.57) MAPTALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL2257581 0.93 MAPT (0.57) MAPTALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL6370565 0.93 MAPT (0.57) MAPTALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL23730320 0.93 MAPT (0.57) MAPTALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL22096217 0.93 MAPT (0.57) MAPTALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL18675715 0.93 MAPT (0.61) MAPTALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL21524304 0.93 MAPT (0.61) MAPTALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL22722749 0.92 ALDH1A1 (0.48) MAPTALDH1A1HPGDSMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10851056-B2 Compound for organic optoelectronic device, organic optoelectronic device and display apparatus SAMSUNG SDI CO., LTD. (KR) 2020-12-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10851056-B2 Compound for organic optoelectronic device, organic optoelectronic device and display apparatus OXER1, OR10J3, AOX1 MAPT 2972/4885ALDH1A1 27/4885HPGD 1723/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.